- Previous Close
0.6290 - Open
0.6290 - Bid 0.6210 x --
- Ask 0.6300 x --
- Day's Range
0.6040 - 0.6500 - 52 Week Range
0.5140 - 4.7300 - Volume
904,500 - Avg. Volume
3,917,053 - Market Cap (intraday)
107.597M - Beta (5Y Monthly) 2.53
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6000 - Earnings Date Nov 27, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
www.immunovia.com10
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: IMMNOV.ST
View MorePerformance Overview: IMMNOV.ST
Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IMMNOV.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IMMNOV.ST
View MoreValuation Measures
Market Cap
106.75M
Enterprise Value
78.70M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
69.11
Price/Book (mrq)
5.42
Enterprise Value/Revenue
88.93
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-55.94%
Return on Equity (ttm)
-153.82%
Revenue (ttm)
885k
Net Income Avi to Common (ttm)
-116.12M
Diluted EPS (ttm)
-0.6000
Balance Sheet and Cash Flow
Total Cash (mrq)
36.76M
Total Debt/Equity (mrq)
44.17%
Levered Free Cash Flow (ttm)
-62.27M